What is the role of duvelisib in follicular lymphoma (FL) treatment?

Updated: Jan 16, 2019
  • Author: Francisco J Hernandez-Ilizaliturri, MD; Chief Editor: Koyamangalath Krishnan, MD, FRCP, FACP  more...
  • Print


Duvelisib is indication for recurrent or relapsed FL after at least 2 prior systemic therapies [21] :

  • Initial dose: 25 mg PO BID; modify dosage for toxicity

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!